HGSNAT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.393900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.144600E-01
Normal-vs-Stage2
1.163990E-01
Normal-vs-Stage3
1.747580E-01
Normal-vs-Stage4
6.065800E-01
Stage1-vs-Stage2
7.082200E-01
Stage1-vs-Stage3
2.480400E-01
Stage1-vs-Stage4
7.830400E-01
Stage2-vs-Stage3
1.922420E-01
Stage2-vs-Stage4
4.883800E-01
Stage3-vs-Stage4
2.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.811900E-02
Normal-vs-AfricanAmerican
3.257400E-01
Normal-vs-Asian
2.511000E-01
Caucasian-vs-AfricanAmerican
7.544200E-01
Caucasian-vs-Asian
8.925000E-01
AfricanAmerican-vs-Asian
7.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.446200E-01
Normal-vs-Female
5.491600E-02
Male-vs-Female
6.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.802600E-01
Normal-vs-Age(41-60Yrs)
2.474200E-01
Normal-vs-Age(61-80Yrs)
7.178000E-02
Normal-vs-Age(81-100Yrs)
4.164100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.057400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.901600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.397600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.818140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.220200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.066200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.077770E-01
Normal-vs-Daily Drinker
1.581550E-01
Normal-vs-Weekly Drinker
2.221600E-01
Normal-vs-Occasional Drinker
3.495200E-01
Normal-vs-Social Drinker
4.127000E-01
Non Drinker-vs-Daily Drinker
5.467200E-01
Non Drinker-vs-Weekly Drinker
5.976000E-01
Non Drinker-vs-Occasional Drinker
6.670000E-01
Non Drinker-vs-Social Drinker
8.867600E-02
Daily Drinker-vs-Weekly Drinker
3.851400E-01
Daily Drinker-vs-Occasional Drinker
8.084800E-01
Daily Drinker-vs-Social Drinker
7.733900E-02
Weekly Drinker-vs-Occasional Drinker
3.484600E-01
Weekly Drinker-vs-Social Drinker
3.062200E-01
Occasional Drinker-vs-Social Drinker
2.731600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.997010E-01
Normal-vs-Grade 2
3.114500E-02
Normal-vs-Grade 3
1.777890E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.660810E-01
Grade 1-vs-Grade 3
5.257900E-02
Grade 1-vs-Grade 4
1.997010E-01
Grade 2-vs-Grade 3
2.671600E-01
Grade 2-vs-Grade 4
3.114500E-02
Grade 3-vs-Grade 4
1.777890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.274770E-01
Normal-vs-NonDiabetic
6.975500E-02
Diabetic-vs-NonDiabetic
5.992000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.828200E-01
Normal-vs-NoPancreatitis
5.494500E-02
Pancreatitis-vs-NoPancreatitis
1.621450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.984500E-02
Normal-vs-N1
1.283830E-01
N0-vs-N1
1.646220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.303200E-01
Normal-vs-TP53-NonMutant
1.222230E-01
TP53-Mutant-vs-TP53-NonMutant
1.832420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
